Zhang Yu-Qi

Zhang Yu-Qi


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2010 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
TJTao Jiang
Tao Jiang
GJGe Jia
Ge Jia
ZMZhenYu Ma
ZhenYu Ma
SLShiQi Luo
ShiQi Luo
ZYZhang Yu-Qi
Zhang Yu-Qi


17 September 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
XMXin-Long Ma
Xin-Long Ma
FSFeng Shang
Feng Shang
WNWei Ni
Wei Ni
JZJin Zhu
Jin Zhu
BLBin Luo
Bin Luo
ZYZhang Yu-Qi
Zhang Yu-Qi

16 September 2019 in PeerJ
Verified
Journal Article
Open access
PDF file
JZJin Zhu
Jin Zhu
ZYZhang Yu-Qi
Zhang Yu-Qi
Background Engrailed 1 (EN1), as a member of homeobox-containing transcription factors, participates in the development of the brain. High expressions of EN1 exist in various tumors. However, the role of EN1 in lower grade glioma (LGG) is still unknown. Methods Coefficients of Cox regression were examined by data mining among 13 cancer types using OncoLnc to validate EN1 expressions in LGG patients from The Cancer Genome Atlas database (TCGA). Bioinformatic analysis was performed by using R2 and the UCSC Xena browser based on the data from 273 glioma cases in GSE16011 from GEO datasets and 530 cases of LGG patients in TCGA. Cases in GSE16011 were divided into two groups according to IDH1 mutation status. Cases in TCGA-LGG were classified to subtypes according to histopathological results, IDH1 mutation status and 1p19q status. The Kaplan–Meier survival curves were performed to analyze the relationship between EN1 expressions and clinicopathological characteristics and survival time respectively. Results Cox regression results showed that LGG was ranked statistically first among 13 different cancer types according to the false discovery rate (FDR) correction. Results from GSE16011 showed that: glioma, LGG and LGG with IDH1 mutation patients with high EN1 expressions had significantly shorter 5, 10, and 15-year overall survival time (OS) (p < 0.001). Similar results from TCGA-LGG showed that LGG patients with high EN1 expressions had significantly shorter 15-year OS, irrespective of IDH1 mutation and 1p19q co-deletion (p < 0.001). The astrocytoma subgroup showed highest levels of EN1 expression and shortest 5, 10 and 15-year OS compared with oligoastrocytoma and oligodendroglioma (p < 0.05). Conclusion EN1 can be used as a prognostic marker in LGG patients, combined with IDH1 mutation and 1p19q co-deletion.

1 September 2018 in World Neurosurgery
Verified
Journal Article
Closed access
RZRongsong Zhou
Rongsong Zhou
YMYu Ma
Yu Ma
WLWei Liu
Wei Liu
SMSuhua Miao
Suhua Miao
ZYZhang Yu-Qi
Zhang Yu-Qi

1 May 2021 in World Neurosurgery
Verified
Journal Article
Closed access
JZJin Zhu
Jin Zhu
LHLi-Bo Hu
Li-Bo Hu
YZYa-Peng Zhao
Ya-Peng Zhao
ZYZhang Yu-Qi
Zhang Yu-Qi